Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00219843
Status:
COMPLETED
Last Update Posted:
2007-08-23
First Post:
2005-09-14
Brief Title:
Intralesional PV-10 Chemoablation of Metastatic Melanoma
Sponsor:
Provectus Pharmaceuticals
Organization:
Provectus Pharmaceuticals
Organization Data
Organization:
Provectus Pharmaceuticals
Class:
INDUSTRY
Study ID:
PV-10-MM-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Provectus Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None